Outcomes following partial nephrectomy by tumor size.

[1]  B. K. Park.  Re: Renal mass biopsy--a renaissance? B. R. Lane, M. K. Samplaski, B. R. Herts, M. Zhou, A. C. Novick and S. C. Campbell J Urol 2008; 179: 20-27. , 2009, The Journal of urology.

[2]  J. Heimbach,et al.  Re: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. , 2008, The Journal of urology.

[3]  S. Pahernik,et al.  Prognostic stratification of localized renal cell carcinoma by tumor size. , 2008, The Journal of urology.

[4]  K. Bensalah,et al.  Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. , 2008, The Journal of urology.

[5]  R. Uzzo,et al.  Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.

[6]  Stephen A Boorjian,et al.  Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. , 2008, The Journal of urology.

[7]  J. Cadeddu,et al.  Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours , 2007, BJU international.

[8]  M. Kattan,et al.  A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. , 2007, The Journal of urology.

[9]  R. Herwig,et al.  Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small , 2007, BJU international.

[10]  Jihad H Kaouk,et al.  Ablative techniques for the management of kidney cancer , 2007, Nature Clinical Practice Urology.

[11]  P. Crispen,et al.  The natural history of untreated renal masses , 2007, BJU international.

[12]  R. Uzzo,et al.  Enhancing renal masses with zero net growth during active surveillance. , 2007, The Journal of urology.

[13]  M. Stifelman,et al.  Impact of discordant radiologic and pathologic tumor size on renal cancer staging. , 2006, Urology.

[14]  A. Hanlon,et al.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. , 2006, The Journal of urology.

[15]  L. Kavoussi,et al.  Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography. , 2005, The Journal of urology.

[16]  R. M. Hsu,et al.  Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. , 2004, AJR. American journal of roentgenology.

[17]  J. Cheville,et al.  Solid renal tumors: an analysis of pathological features related to tumor size. , 2003, The Journal of urology.

[18]  Matthew P. Rutman,et al.  Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors. , 2002, Urology.

[19]  S. Sharma,et al.  Radiographic versus pathologic size of renal tumors: implications for partial nephrectomy. , 2001, Urology.

[20]  A. Novick,et al.  Nephron sparing surgery for renal tumors: indications, techniques and outcomes. , 2001, The Journal of urology.

[21]  A. Novick,et al.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. , 2000, The Journal of urology.

[22]  A. Novick,et al.  Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. , 1999, The Journal of urology.

[23]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[24]  L. Sobin,et al.  TNM classification of malignant tumors, fifth edition (1997) , 1997, Cancer.

[25]  M. Zhou,et al.  Renal mass biopsy--a renaissance? , 2008, The Journal of urology.

[26]  J. Cadeddu,et al.  Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. , 2008, The Journal of urology.

[27]  S. Boorjian,et al.  Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumors: Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA, Department of Urology, University of Texas, Southwestern Medical Center, Dallas, TX , 2008 .

[28]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.